Description: An outcome-based neurohormonal regulation pathway designed for individuals with cycle-linked mood dysregulation such as PMDD. This pathway focuses on stabilizing luteal-phase hormone signaling, reducing neuroinflammation, and improving brain resilience without defaulting to ovulation suppression. Care is structured around symptom timing, progesterone signaling, thyroid optimization, and nervous system support.